Report #2877284

Received Dec 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 77 yrs
State: —
Recovered: Unknown
Vaccinated: Dec 8, 2025
Onset: Dec 8, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Chills

Symptom narrative

Shivering; This non-serious case was reported by a consumer and described the occurrence of shivering in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 08-DEC-2025, the patient received the 2nd dose of Shingrix. On 08-DEC-2025, less than a day after receiving Shingrix, the patient experienced shivering (Verbatim: Shivering). The outcome of the shivering was unknown. It was unknown if the reporter considered the shivering to be related to Shingrix. It was unknown if the company considered the shivering to be related to Shingrix. Additional Information: GSK Receipt Date: 08-DEC-2025 The batch number was not provided, and we are unable to contact the reporter.